Stifel Financial’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Stifel Financial’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-24,500	Closed	-$8K	–	2624
2016 Q1	$8K	Buy	+24,500	New	+$8K	﹤0.01%	2224
2015 Q4	–	Sell	-24,500	Closed	-$11K	–	2460
2015 Q3	$11K	Hold	24,500	–	–	﹤0.01%	2233
2015 Q2	$12K	Hold	24,500	–	–	﹤0.01%	2338
2015 Q1	$18K	Hold	24,500	–	–	﹤0.01%	2274
2014 Q4	$13K	Sell	24,500 -24,500	-50%	-$14.8K	﹤0.01%	2288
2014 Q3	$28K	Hold	49,000	–	–	﹤0.01%	2173
2014 Q2	$63K	Buy	49,000 +7,500	+18%	+$10.7K	﹤0.01%	2131
2014 Q1	$75K	Buy	+41,500	New	+$70.1K	﹤0.01%	2030

Stifel Financial's ONCY Position: Q2 2016 in Review

Stifel Financial sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q2 2016, closing a stake of 24,500 shares — an estimated $8K sold.

Stifel Financial first reported a position in ONCY in Q1 2014 and held it in 8 quarters. The position peaked at $75K in Q1 2014. 1 fund tracked by Wall St. Rank holds ONCY as of Q2 2016.

Stifel Financial reported no remaining ONCOLYTICS BIOTECH INC position as of Q2 2016 after selling out during the quarter.
Stifel Financial sold 24,500 ONCOLYTICS BIOTECH INC shares in Q2 2016, an estimated $8K.
Stifel Financial first reported a position in ONCOLYTICS BIOTECH INC in Q1 2014 and held it in 8 quarters.
Stifel Financial's ONCOLYTICS BIOTECH INC position peaked at $75K in Q1 2014.
1 fund tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q2 2016.

Based on Stifel Financial's 13F filing for Q2 2016, filed 17 Aug 2016.